Ratings agency Standard & Poor's (S&P) has highlighted concerns over life settlement securitisations (LSS).
The agency - which doesn't currently rate the products - questioned the actuarial assumptions underpinning transactions, the accuracy of independent medical reviews, conflicting legal opinion...